Evelo Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch EVLO and buy or sell other stocks, ETFs, and their options commission-free!About EVLO
Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology.
CEOBalkrishan Gill
CEOBalkrishan Gill
Employees66
Employees66
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2014
Founded2014
Employees66
Employees66
EVLO Key Statistics
Market cap11.41K
Market cap11.41K
Price-Earnings ratio-3.13
Price-Earnings ratio-3.13
Dividend yield—
Dividend yield—
Average volume43.16M
Average volume43.16M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.29
52 Week high$3.29
52 Week low$0.0243
52 Week low$0.0243
Stock Snapshot
As of today, Evelo Biosciences(EVLO) shares are valued at $0.00. The company's market cap stands at 11.41K, with a P/E ratio of -3.13.
On 2026-02-04, Evelo Biosciences(EVLO) stock opened at —, reached a high of —, and a low of —.
Evelo Biosciences(EVLO) shares are trading with a volume of 0, against a daily average of 43.16M.
During the past year, Evelo Biosciences(EVLO) stock moved between $0.02 at its lowest and $3.29 at its peak.
During the past year, Evelo Biosciences(EVLO) stock moved between $0.02 at its lowest and $3.29 at its peak.
People also own
Based on the portfolios of people who own EVLO. This list is generated using Robinhood data, and it’s not a recommendation.